SUD Execs Say Ozempic & MAT Injectables & AI Likely to Shape 2025

This post was originally published on this site

Addiction Recovery Bulletin

EVERYONE MAKES MONEY –

Dec. 11, 2024 – John Driscoll, president and CEO of Caron Treatment Centers “In 2024, we’ve seen payers evolve reimbursement models away from fee-for-service and towards value-based structures (like monthly bundles), while ceasing payments for unnecessary services like drug tests…As SUD providers compete for these contracts on quality and cost, tech-enabled models are winning, and this will continue in 2025 and beyond.” “The biggest challenge remains the workforce, workforce, workforce. Not enough people are coming into the industry. The degrees needed, such as a Master of Social Work or Psychology are expensive, and we have an aging workforce. This is a second career for many professionals who work in the field, which means we are aging faster than other industries. Stigma also continues to be a hurdle. The legalization of cannabis and the normalization of microdosing creates challenges moving forward as we’re seeing misuse and addiction increase.”

– John Driscoll, president and CEO of Caron Treatment Centers

CONTINUE@BHBusiness

The post SUD Execs Say Ozempic & MAT Injectables & AI Likely to Shape 2025 appeared first on Addiction/Recovery eBulletin.